MiMedx Group Inc

Healthcare · Biotechnology

4.60$ -0.9% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

MiMedx Group Inc (MDXG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 281 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MDXG
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	182	193	188	200	179	121	121	121	121	123	107	170	179	123	123	151	213	202	191	187	181	188	174	169	173	171	168	176	189	239	222	230	244	264	270	291	319	343	309	281
Current Assets	106	127	122	133	114	49	–	–	–	74	57	123	134	74	74	108	171	161	150	148	142	149	136	131	136	134	132	141	155	164	139	154	172	192	200	221	254	277	240	205
Cash	18	34	31	48	37	27	–	–	–	45	28	97	94	45	45	48	110	96	85	85	91	87	76	73	73	66	61	69	81	82	48	69	89	104	106	119	142	166	160	136
Cash & Short-Term Investments	18	34	31	48	37	27	–	–	–	45	28	97	94	45	54	48	110	96	85	85	91	87	76	73	73	66	61	69	81	82	48	69	89	104	106	119	142	166	160	136
Receivables	63	67	67	61	60	0.7	–	–	–	51	0.5	0.5	22	0.5	51	30	44	35	35	47	37	40	38	38	41	44	45	49	49	54	57	53	54	56	62	69	78	76	46	41
Inventory	18	18	16	15	10	9.5	–	–	–	16	16	15	12	16	16	11	11	10	12	10	11	11	13	13	14	13	15	17	19	21	24	25	24	24	24	25	27	25	26	21
Property, Plant & Equipment	14	14	14	14	13	–	–	–	–	17	16	15	17	16	15	14	10	11	11	13	13	14	13	12	12	11	11	–	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	27	20	20	20	20	20	–	–	–	20	20	20	20	20	20	20	20	20	20	20	20	20	20	20	20	20	20	19	19	19	19	19	19	19	19	19	19	19	19	19
Intangible Assets	27	23	23	22	10	10	–	–	–	9.6	8.3	8.1	8.0	9.6	9.6	7.4	7.2	6.0	5.9	5.8	5.6	5.4	5.3	5.1	5.0	5.9	5.7	5.6	5.4	5.3	13	12	11	12	11	12	11	14	13	12
Total Liabilities	58	60	59	53	36	47	–	–	–	73	69	146	140	73	73	128	109	111	107	102	94	95	89	90	100	189	94	97	188	96	66	62	63	71	68	74	80	86	66	65
Current Liabilities	42	51	50	52	35	46	–	–	–	72	64	78	73	72	72	64	57	59	55	51	42	42	37	37	46	44	41	44	44	46	42	40	42	46	43	50	58	64	45	38
Short-Term Debt	–	0.0	0.0	0.0	0.0	–	–	–	–	–	–	3.8	3.8	3.8	3.8	5.0	–	1.2	1.3	–	–	1.2	–	–	2.0	1.4	1.8	2.1	–	1.5	1.0	1.0	1.0	2.3	1.1	1.3	1.4	2.8	1.5	1.5
Accounts Payable	11	11	11	12	8.8	8.5	–	–	–	15	67	11	9.4	15	9.8	12	9.0	8.8	6.9	11	6.9	7.4	8.1	8.1	8.8	8.8	7.8	8.2	9.2	9.0	9.7	7.6	6.9	7.4	8.9	8.5	11	15	11	8.3
Long-Term Debt	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	63	62	62	62	61	48	48	48	48	48	48	48	48	48	49	49	49	49	48	18	18	18	18	18	17	17	16	16	16
Shareholders' Equity	123	133	129	147	142	74	–	–	–	50	38	25	40	50	30	23	104	91	84	85	87	93	85	79	73	-18	75	80	1.3	143	156	168	181	193	203	217	239	257	243	216
Retained Earnings	-32	-26	-22	-14	3.7	-47	–	–	–	-77	-90	-107	-95	-77	-77	-115	-135	-151	-160	-162	-164	-162	-172	-183	-191	-18	-197	-196	-187	-134	-124	-107	-99	-91	-84	-75	-58	-43	-54	-68
Shares Outstanding	112	114	114	117	118	114	114	111	106	106	106	107	110	106	106	108	108	109	109	110	111	113	112	113	113	114	114	116	119	148	150	149	148	149	150	149	150	150	148	148

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings